Masimo Corporation (MASI): Price and Financial Metrics

Masimo Corporation (MASI): $286.12

0.97 (+0.34%)

POWR Rating

Component Grades














  • MASI scores best on the Quality dimension, with a Quality rank ahead of 86.79% of US stocks.
  • MASI's strongest trending metric is Stability; it's been moving up over the last 51 weeks.
  • MASI's current lowest rank is in the Momentum metric (where it is better than 38.49% of US stocks).

MASI Stock Summary

  • MASI's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 5,563.67 -- higher than 99.34% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for MASI is currently 82.56, higher than 94.65% of US stocks with positive operating cash flow.
  • The ratio of debt to operating expenses for Masimo Corp is higher than it is for about only 0.45% of US stocks.
  • Stocks that are quantitatively similar to MASI, based on their financial statements, market capitalization, and price volatility, are TTWO, PLAB, CPRX, OSS, and BCOV.
  • MASI's SEC filings can be seen here. And to visit Masimo Corp's official web site, go to

MASI Valuation Summary

  • In comparison to the median Healthcare stock, MASI's price/sales ratio is 234.21% higher, now standing at 12.7.
  • MASI's price/sales ratio has moved up 8.1 over the prior 171 months.
  • MASI's price/sales ratio has moved up 8.1 over the prior 171 months.

Below are key valuation metrics over time for MASI.

Stock Date P/S P/B P/E EV/EBIT
MASI 2021-08-31 12.7 10.7 66.8 55.7
MASI 2021-08-30 12.9 10.9 68.0 56.8
MASI 2021-08-27 13.0 11.0 68.2 57.0
MASI 2021-08-26 12.9 10.9 68.0 56.8
MASI 2021-08-25 13.1 11.1 69.1 57.7
MASI 2021-08-24 13.3 11.3 70.2 58.7

MASI Growth Metrics

  • Its 5 year cash and equivalents growth rate is now at 357.93%.
  • The 3 year price growth rate now stands at 228.86%.
  • Its 5 year net income to common stockholders growth rate is now at 153.72%.
Over the past 30 months, MASI's revenue has gone up $319,038,000.

The table below shows MASI's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 1,177.327 190.161 223.692
2021-03-31 1,173.162 227.868 229.229
2020-12-31 1,143.744 210.963 240.302
2020-09-30 1,096.2 216.769 222.554
2020-06-30 1,047.099 226.921 222.234
2020-03-31 975.798 221.527 211.35

MASI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MASI has a Quality Grade of B, ranking ahead of 86.76% of graded US stocks.
  • MASI's asset turnover comes in at 0.702 -- ranking 52nd of 185 Medical Equipment stocks.
  • ICUI, ZYXI, and BLFS are the stocks whose asset turnover ratios are most correlated with MASI.

The table below shows MASI's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-03 0.702 0.642 0.380
2021-04-03 0.705 0.643 0.387
2021-01-02 0.700 0.650 0.408
2020-09-26 0.705 0.660 0.413
2020-06-27 0.720 0.669 0.414
2020-03-28 0.721 0.680 0.402

MASI Price Target

For more insight on analysts targets of MASI, see our MASI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $298.80 Average Broker Recommendation 1.5 (Moderate Buy)

MASI Stock Price Chart Interactive Chart >

Price chart for MASI

MASI Price/Volume Stats

Current price $286.12 52-week high $288.27
Prev. close $285.15 52-week low $205.10
Day low $284.41 Volume 176,500
Day high $287.59 Avg. volume 303,144
50-day MA $274.36 Dividend yield N/A
200-day MA $251.68 Market Cap 15.75B

Masimo Corporation (MASI) Company Bio

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies worldwide. The Company's core business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. The company was founded in 1989 and is based in Irvine, California.

MASI Latest News Stream

Event/Time News Detail
Loading, please wait...

MASI Latest Social Stream

Loading social stream, please wait...

View Full MASI Social Stream

Latest MASI News From Around the Web

Below are the latest news stories about Masimo Corp that investors may wish to consider to help them evaluate MASI as an investment opportunity.

Pulse Oximeter Market will grow substantially by 2027, Globally | Industry Overview by Top Players - Medtronic, Carefusion Corp., GE Healthcare, Philips Healthcare, Masimo, CAS Medical Systems

A comprehensive overview of the Pulse Oximeter Market is recently added by UnivDatos Market Insights to its humongous database. The Pulse Oximeter Market report has been aggregated by collecting informative data of various dynamics such as market drivers, restraints, and

OpenPR | October 13, 2021

Masimo to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, October 26

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release third quarter 2021 financial results for the period ended October 2, 2021, after the market closes on Tuesday, October 26, 2021. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer. To register for the conference call and receive the dial-in number, please u

Business Wire | October 12, 2021

Coverage Initiated by Raymond James 3 stars for Masimo (MASI)

Stock analysts at Raymond James - 3 stars initiated coverage on shares of Masimo (MASI) in a report issued on monday. The brokerage set a Market Perform rating on the Medical stock. The post Coverage Initiated by Raymond James 3 stars for Masimo (MASI) appeared first on .

Stock Market Daily | October 12, 2021

Masimo and University Hospitals Partner to Combat Nurse Burnout

IRVINE, Calif.--(BUSINESS WIRE)--University Hospitals is using Masimo Patient SafetyNet to improve workflows and reduce workloads in order to combat nurse burnout.

Business Wire | October 4, 2021

Masimo's (NASDAQ:MASI) earnings growth rate lags the 35% CAGR delivered to shareholders

Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies...

Yahoo | October 4, 2021

Read More 'MASI' Stories Here

MASI Price Returns

1-mo 4.25%
3-mo 7.15%
6-mo 15.81%
1-year 20.57%
3-year 146.72%
5-year 384.21%
YTD 6.61%
2020 69.80%
2019 47.21%
2018 26.62%
2017 25.82%
2016 62.37%

Continue Researching MASI

Want to see what other sources are saying about Masimo Corp's financials and stock price? Try the links below:

Masimo Corp (MASI) Stock Price | Nasdaq
Masimo Corp (MASI) Stock Quote, History and News - Yahoo Finance
Masimo Corp (MASI) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8753 seconds.